Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
about
Usefulness of lipid apheresis in the treatment of familial hypercholesterolemiaFamilial hypercholesterolemia: Review of diagnosis, screening, and treatmentChallenges in the Diagnosis and Treatment of Homozygous Familial HypercholesterolemiaFamilial hypercholesterolemia: an under-recognized but significant concern in cardiology practiceExploring predisposition and treatment response--the promise of genomicsCriteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab PopulationTreatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH RegistryClinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.Investigation of the predictive value of speckle tracking imaging for the assessment of cardiac function and clinical prognosis in patients with hypercholesterolemia.Genealogical analysis as a new approach for the investigation of drug intolerance heritability.Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy.Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile.Familial hypercholesterolemiaMolecular genetic studies of complex phenotypes.Familial hypercholesterolemia presenting with multiple nodules of the hands and elbow.Development and rescue of human familial hypercholesterolaemia in a xenograft mouse modelTemporal trends in lipid screening and therapy among youth from 2002 to 2012Reducing the burden of disease and death from familial hypercholesterolemia: a call to actionHow Do PCSK9 Inhibitors Stack Up to Statins for Low-Density Lipoprotein Cholesterol Control?Emerging LDL therapies: Using human genetics to discover new therapeutic targets for plasma lipids.Genetics of Dyslipidemia.Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study.Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia.My Approach to the Patient With Familial Hypercholesterolemia.Treatment of familial hypercholesterolemia: is there a need beyond statin therapy?Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.Novel treatments for familial hypercholesterolemia: pharmacogenetics at work.Recommendations for the management of patients with familial hypercholesterolemia.Familial hypercholesterolemia--epidemiology, diagnosis, and screening.Genetics of familial hypercholesterolemia.The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia.Update of Clinical Trials of Anti-PCSK9 Antibodies.Type of LDLR mutation and the pharmacogenetics of familial hypercholesterolemia treatment.Therapeutic Management of Familial Hypercholesterolemia: Current and Emerging Drug Therapies.PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumab.Frequency of Achilles Tendon Xanthoma in Patients with Acute Coronary Syndrome.Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia.Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals.Genetic identification of familial hypercholesterolemia within a single U.S. health care system.
P2860
Q21284511-93A2BD3A-D549-47D8-8C54-AE7255BB5969Q26770143-9532277B-53EC-432E-A714-C088B6C7B119Q26787050-7CF4BE36-62CA-401C-A505-724300FE16DCQ26828401-0B22B525-A2C4-4CC2-BB85-FD3EADE06247Q26851609-288880E9-8FA8-4B92-ABEB-135ACC5ECA54Q27025178-8DF70A21-50F1-4840-9631-45A04D606288Q31063192-B70E8114-0303-4F7A-A299-CEFA94341621Q31161044-A9B1C56D-F2CD-4F67-90DA-B4AB7560CDADQ33744616-7F7A9DF8-3F55-4E11-816A-C5A5499DE9A4Q33765249-2EEA063C-1465-4D1C-8D89-F754F90338FCQ34477657-B15FFEE8-3489-47CF-8065-636518560555Q34481404-08093BD9-54F1-426E-84E4-B868A4DDD36BQ34971772-850A46F6-010C-452E-9E97-11234ADF9DA3Q35676062-C7CF0ACC-C5FF-462A-A1F1-B3BD0AC0D0FBQ35841796-D29CB8FA-90B4-4892-87E5-B0701E97B7AFQ36018639-26BEF0C2-9426-4E26-9356-A7E650A5582FQ36034652-8DC720C1-4BD1-4BC2-86BA-76EBB77D8D62Q36381467-F8E1BB1B-F5BF-4E18-8F06-4A0B96E55284Q36385726-F46AD91D-8421-4F5D-AE0E-DD6C3544CE12Q36951750-9F9755E2-D1EC-4F04-8918-BD47DA5DB416Q37021351-6B4E2568-5497-4E89-A434-32497E603270Q37066247-6560E1FC-A5B7-413F-A1E4-A6C86876D06AQ37631057-A888687B-B9F8-47A2-B656-81AB7CC3E13AQ37716374-1AEB3E50-1531-486D-B46D-D69797249ACDQ37731770-81EAB3C3-F1E8-4E4C-A0A4-95A0BFA23538Q37963825-A626A347-D2AE-44F2-9689-2DF103FAA02BQ38132257-CFF660CA-2886-447E-9C40-6F5237A96A9AQ38217797-C06FED99-AA6E-4AA8-87E2-026FCC33C026Q38268915-0EB9AA35-4B9C-455D-AC56-BDF41AD356A6Q38328904-108FA6EB-1151-4D6D-AF46-C2763C4AD1D1Q38364881-2874A374-B13A-412E-86A1-F13755B93D15Q38381808-5AE2D253-B3AA-4DE9-8444-750FD450AEBEQ38444379-22BBA73A-4358-4BF5-B359-420879AC6E8FQ38596963-081EEDAE-1A0B-48CC-B687-59B255AD1FC4Q38673894-33818DA3-7623-4002-9053-9D2A3BADC164Q38748787-412767D5-A676-43D7-B3E9-B66A9DB98A40Q38751768-9E134E46-6DFA-4F87-9E60-2A40CFA42F8CQ38969073-1D6068C3-1555-498C-9A6E-0A82197BE97CQ38987441-91DFB000-1E08-4048-8040-1D0A43B2DD27Q39070299-B6976B9F-B8F3-4BF4-81E3-AB7DE3167AE5
P2860
Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Familial hypercholesterolemias ...... Familial Hypercholesterolemia.
@en
Familial hypercholesterolemias ...... Familial Hypercholesterolemia.
@nl
type
label
Familial hypercholesterolemias ...... Familial Hypercholesterolemia.
@en
Familial hypercholesterolemias ...... Familial Hypercholesterolemia.
@nl
prefLabel
Familial hypercholesterolemias ...... Familial Hypercholesterolemia.
@en
Familial hypercholesterolemias ...... Familial Hypercholesterolemia.
@nl
P2093
P1476
Familial hypercholesterolemias ...... Familial Hypercholesterolemia.
@en
P2093
Christie M Ballantyne
Daniel J Rader
National Lipid Association Expert Panel on Familial Hypercholesterolemia
Paul N Hopkins
Peter P Toth
P356
10.1016/J.JACL.2011.03.452
P407
P433
P577
2011-04-03T00:00:00Z